SOPHARMA AD: Sopharma monthly May 2016

opublikowano: 2016-06-06 12:58

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
Sopharma_monthly_May_2016.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
<html>
<head>

</head>
<body><font face='Times New Roman'>
<p>

</p>
</font></body>
</html>
 <font face='Times New Roman'></font> <font face='Times New Roman'></font> UNI - EN REPORT No 52 / 2016 <html>
<head>

</head>
<body>
</body>
</html>
 <font face='Times New Roman'></font>
Date of issue: 2016-06-06
Short name of the issuer
SOPHARMA AD
Subject
Sopharma monthly May 2016
Official market - legal basis
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych
Unofficial market - legal basis
Contents of the report:
For the first five months of this year, revenues from sales decreased by 13% compared to the same period of 2015, including 3% decrease of domestic sales and a 19% decrease of export sales, which is due to the lower number of workdays in the month of May.
Annexes
File Description
Sopharma monthly May 2016.docSopharma monthly May 2016.doc Sopharma monthly May 2016

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2016-06-06 Ognian Donev Executive director